Literature DB >> 17504024

Unique MicroRNA signature and clinical outcome of cancers.

Sung-Liang Yu1, Hsuan-Yu Chen, Pan-Chyr Yang, Jeremy J W Chen.   

Abstract

MicroRNAs (miRNAs) are endogenous small non-protein-coding RNAs (18-25 nucleotides) that conduct the post-transcriptional repression of hundreds of their target proteins. They regulate many kinds of basic cellular processes including proliferation, differentiation, stress response, and cell death. Recent evidence has shown that deregulation of miRNAs correlates with certain features of diverse cancers (such as tumorigenesis, differentiation status, and outcome of tumor patients), and indicates that miRNAs can act as oncogenes or tumor suppressors. Here, we summarize these recent studies and provide a new perspective on understanding the role of miRNAs in initiation and progression of cancers. We also discuss the future applications of miRNAs in diagnostic and prognostic implications of cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17504024     DOI: 10.1089/dna.2006.0555

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  22 in total

1.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.

Authors:  Chad J Creighton; Michael D Fountain; Zhifeng Yu; Ankur K Nagaraja; Huifeng Zhu; Mahjabeen Khan; Emuejevoke Olokpa; Azam Zariff; Preethi H Gunaratne; Martin M Matzuk; Matthew L Anderson
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

2.  A PCR-based platform for microRNA expression profiling studies.

Authors:  Xiaowei Wang
Journal:  RNA       Date:  2009-02-13       Impact factor: 4.942

3.  Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA.

Authors:  Erkko Ylösmäki; Tanja Hakkarainen; Akseli Hemminki; Tapio Visakorpi; Raul Andino; Kalle Saksela
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

4.  Nicotine upregulates microRNA-21 and promotes TGF-β-dependent epithelial-mesenchymal transition of esophageal cancer cells.

Authors:  Yi Zhang; Tiecheng Pan; Xiaoxuan Zhong; Cai Cheng
Journal:  Tumour Biol       Date:  2014-04-23

5.  A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma.

Authors:  Ge Gao; Hiram A Gay; Rebecca D Chernock; Tian R Zhang; Jingqin Luo; Wade L Thorstad; James S Lewis; Xiaowei Wang
Journal:  Cancer       Date:  2012-06-26       Impact factor: 6.860

6.  MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer.

Authors:  Xiaofan Zhang; Hushan Yang; J Jack Lee; Edward Kim; Scott M Lippman; Fadlo R Khuri; Margaret R Spitz; Reuben Lotan; Waun K Hong; Xifeng Wu
Journal:  Carcinogenesis       Date:  2010-09-05       Impact factor: 4.944

7.  MicroRNA signatures differentiate uterine cancer tumor subtypes.

Authors:  Elena S Ratner; David Tuck; Christine Richter; Sunitha Nallur; Rajeshvari M Patel; Vince Schultz; Pei Hui; Peter E Schwartz; Thomas J Rutherford; Joanne B Weidhaas
Journal:  Gynecol Oncol       Date:  2010-06-09       Impact factor: 5.482

8.  High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation.

Authors:  Guizhi Dong; Xiaoling Liang; Deguang Wang; Huiquan Gao; Ling Wang; Lili Wang; Jingjun Liu; Zhaohui Du
Journal:  Med Oncol       Date:  2014-06-15       Impact factor: 3.064

9.  A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.

Authors:  Sébastien S Hébert; Wang-Xia Wang; Qi Zhu; Peter T Nelson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  In-depth characterization of the microRNA transcriptome in a leukemia progression model.

Authors:  Florian Kuchenbauer; Ryan D Morin; Bob Argiropoulos; Oleh I Petriv; Malachi Griffith; Michael Heuser; Eric Yung; Jessica Piper; Allen Delaney; Anna-Liisa Prabhu; Yongjun Zhao; Helen McDonald; Thomas Zeng; Martin Hirst; Carl L Hansen; Marco A Marra; R Keith Humphries
Journal:  Genome Res       Date:  2008-10-10       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.